177 related articles for article (PubMed ID: 24714026)
1. European recommendations for primary prevention of congenital anomalies: a joined effort of EUROCAT and EUROPLAN projects to facilitate inclusion of this topic in the National Rare Disease Plans.
Taruscio D; Arriola L; Baldi F; Barisic I; Bermejo-Sánchez E; Bianchi F; Calzolari E; Carbone P; Curran R; Garne E; Gatt M; Latos-Bieleńska A; Khoshnood B; Irgens L; Mantovani A; Martínez-Frías ML; Neville A; Rißmann A; Ruggeri S; Wellesley D; Dolk H
Public Health Genomics; 2014; 17(2):115-23. PubMed ID: 24714026
[TBL] [Abstract][Full Text] [Related]
2. Primary prevention of congenital anomalies: recommendable, feasible and achievable.
Taruscio D; Mantovani A; Carbone P; Barisic I; Bianchi F; Garne E; Nelen V; Neville AJ; Wellesley D; Dolk H
Public Health Genomics; 2015; 18(3):184-91. PubMed ID: 25791968
[TBL] [Abstract][Full Text] [Related]
3. Primary Prevention of Congenital Anomalies: Special Focus on Environmental Chemicals and other Toxicants, Maternal Health and Health Services and Infectious Diseases.
Taruscio D; Baldi F; Carbone P; Neville AJ; Rezza G; Rizzo C; Mantovani A
Adv Exp Med Biol; 2017; 1031():301-322. PubMed ID: 29214580
[TBL] [Abstract][Full Text] [Related]
4. A sustainable solution for the activities of the European network for surveillance of congenital anomalies: EUROCAT as part of the EU Platform on Rare Diseases Registration.
Kinsner-Ovaskainen A; Lanzoni M; Garne E; Loane M; Morris J; Neville A; Nicholl C; Rankin J; Rissmann A; Tucker D; Martin S
Eur J Med Genet; 2018 Sep; 61(9):513-517. PubMed ID: 29597096
[TBL] [Abstract][Full Text] [Related]
5. Primary prevention as an essential factor ensuring sustainability of health systems: the example of congenital anomalies.
Taruscio D; Bermejo-Sánchez E; Salerno P; Mantovani A
Ann Ist Super Sanita; 2019; 55(3):258-264. PubMed ID: 31553320
[TBL] [Abstract][Full Text] [Related]
6. EUROPLAN: a project to support the development of national plans on rare diseases in Europe.
Taruscio D; Gentile AE; De Santis M; Ferrelli RM; Posada de la Paz M; Hens M; Huizer J; Fregonese L; Stefanov R; Bottarelli V; Weinman A; Le Cam Y; Gavhed D; Mincarone P; Bushby K; Frazzica RG; Donati C; Vittozzi L; Jessop E
Public Health Genomics; 2013; 16(6):278-87. PubMed ID: 24503588
[TBL] [Abstract][Full Text] [Related]
7. Paper 1: The EUROCAT network--organization and processes.
Boyd PA; Haeusler M; Barisic I; Loane M; Garne E; Dolk H
Birth Defects Res A Clin Mol Teratol; 2011 Mar; 91 Suppl 1():S2-15. PubMed ID: 21384531
[TBL] [Abstract][Full Text] [Related]
8. [Differences in folic-acid policy and the prevalence of neural-tube defects in Europe; recommendations for food fortification in a EUROCAT report].
Meijer WM; de Walle HE
Ned Tijdschr Geneeskd; 2005 Nov; 149(46):2561-4. PubMed ID: 16320666
[TBL] [Abstract][Full Text] [Related]
9. Toward public health nutrition strategies in the European Union to implement food based dietary guidelines and to enhance healthier lifestyles.
Stockley L
Public Health Nutr; 2001 Apr; 4(2A):307-24. PubMed ID: 11688436
[TBL] [Abstract][Full Text] [Related]
10. EUROCAT: 25 years of European surveillance of congenital anomalies.
Dolk H
Arch Dis Child Fetal Neonatal Ed; 2005 Sep; 90(5):F355-8. PubMed ID: 16113149
[TBL] [Abstract][Full Text] [Related]
11. National plans and strategies on rare diseases in Europe.
Taruscio D; Vittozzi L; Stefanov R
Adv Exp Med Biol; 2010; 686():475-91. PubMed ID: 20824461
[TBL] [Abstract][Full Text] [Related]
12. [Primary prevention of congenital defects].
Nazer J
Rev Med Chil; 2004 Apr; 132(4):501-8. PubMed ID: 15382524
[TBL] [Abstract][Full Text] [Related]
13. Exploring the usability of EUCERD core indicators for rare diseases.
Ferrelli RM; De Santis M; Gentile AE; Taruscio D
Ann Ist Super Sanita; 2015; 51(4):342-5. PubMed ID: 26783222
[TBL] [Abstract][Full Text] [Related]
14. [Monitoring of pregnancies exposed to drugs in France: the experience of the registries of congenital malformations].
Doray B
Therapie; 2014; 69(1):47-51. PubMed ID: 24698188
[TBL] [Abstract][Full Text] [Related]
15. Policies and actions to tackle rare diseases at European level.
Montserrat A; Taruscio D
Ann Ist Super Sanita; 2019; 55(3):296-304. PubMed ID: 31553326
[TBL] [Abstract][Full Text] [Related]
16. Centres of Expertise and European Reference Networks: key issues in the field of rare diseases. The EUCERD Recommendations.
Taruscio D; Gentile AE; Evangelista T; Frazzica RG; Bushby K; Montserrat AM
Blood Transfus; 2014 Apr; 12 Suppl 3(Suppl 3):s621-5. PubMed ID: 24922304
[TBL] [Abstract][Full Text] [Related]
17. [Prevention of neural tube defects with periconceptional folic acid supplementation in Europe].
Christiansen M; Garne E
Ugeskr Laeger; 2005 Aug; 167(32):2875-6. PubMed ID: 16109189
[TBL] [Abstract][Full Text] [Related]
18. Preconception care.
Berghella V; Buchanan E; Pereira L; Baxter JK
Obstet Gynecol Surv; 2010 Feb; 65(2):119-31. PubMed ID: 20100361
[TBL] [Abstract][Full Text] [Related]
19. A review of European guidelines on periconceptional folic acid supplementation.
Cawley S; Mullaney L; McKeating A; Farren M; McCartney D; Turner MJ
Eur J Clin Nutr; 2016 Feb; 70(2):143-54. PubMed ID: 26350391
[TBL] [Abstract][Full Text] [Related]
20. [Epidemiologic surveillance of congenital abnormalities using the EUROCAT Register].
De Wals P; Dolk H; Bertrand F; Gillerot Y; Weatherall JA; Lechat MF
Rev Epidemiol Sante Publique; 1988; 36(4-5):273-82. PubMed ID: 3146112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
